What is CRISPR Therapeutics AG's P/S Ratio?

CRISPR Therapeutics AG (CRSP) P/S Ratio is 360.96x based on the latest available daily valuation data on Chartloom.

How to interpret P/S Ratio for CRISPR Therapeutics AG?

Interpreting P/S Ratio for CRISPR Therapeutics AG depends on industry, growth expectations, profitability, and peer multiples.

High P/S ratios reflect expectations for future margin expansion or rapid growth.

Compare to peers with similar gross-margin profiles.

$CRSP

Health Care · Biotechnology

$CRSP

Health Care · Biotechnology

Market cap divided by sales over the last 12 months. Useful for companies that aren’t profitable yet.

Latest P/S Ratio

360.96x

As of Oct 22, 2026

P/S Ratio

Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

Recent P/S Ratio history

Daily readings for the most recent trading days on record.

How is P/S Ratio calculated?